Loading...
Use of carnosine in the prevention of cardiometabolic risk factors in overweight and obese individuals: study protocol for a randomised, double-blind placebo-controlled trial
INTRODUCTION: Carnosine, an over the counter food supplement, has been shown to improve glucose metabolism as well as cardiovascular risk factors in animal and human studies through its anti-inflammatory, antioxidative, antiglycating and chelating properties. The aim of this study is to establish if...
Na minha lista:
| Udgivet i: | BMJ Open |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Publishing Group
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8126302/ https://ncbi.nlm.nih.gov/pubmed/33986049 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2020-043680 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|